ABBV
AbbVie IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$373.77B
P/E Ratio
103.08
EPS
$2.05
Beta
0.36
52W High
$239.13
52W Low
$171.00
50-Day MA
$214.89
200-Day MA
$217.85
Dividend Yield
2.46%
Profit Margin
5.79%
Forward P/E
14.95
PEG Ratio
0.50
About AbbVie Inc
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Fundamentals
| Revenue (TTM) | $62.82B |
| Gross Profit (TTM) | $45.25B |
| EBITDA | $30.00B |
| Operating Margin | 31.60% |
| Return on Equity | 62.30% |
| Return on Assets | 9.81% |
| Revenue/Share (TTM) | $35.50 |
| Book Value | $-1.85 |
| Price-to-Book | 50.46 |
| Price-to-Sales (TTM) | 5.95 |
| EV/Revenue | 6.94 |
| EV/EBITDA | 49.47 |
| Quarterly Earnings Growth (YoY) | -45.80% |
| Quarterly Revenue Growth (YoY) | 12.40% |
| Shares Outstanding | $1.77B |
| Float | $1.77B |
| % Insiders | 0.12% |
| % Institutions | 76.41% |
Historical Volatility
HV 10-Day
31.26%
HV 20-Day
28.03%
HV 30-Day
25.39%
HV 60-Day
27.24%
HV Rank
46.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($249.27 target)
8
Strong Buy14
Buy9
HoldData last updated: 5/1/2026